Indigenous Human Cutaneous Leishmaniasis caused by Leishmania tropica in Kenya

Yemane Mebrahtu

Search for other papers by Yemane Mebrahtu in
Current site
Google Scholar
PubMed
Close
,
Phillip Lawyer

Search for other papers by Phillip Lawyer in
Current site
Google Scholar
PubMed
Close
,
John Githure Biomedical Sciences Research Centre

Search for other papers by John Githure in
Current site
Google Scholar
PubMed
Close
,
Piet Kager Medical Research Center, Kenya Medical Research Institute, Nairobi, Kenya

Search for other papers by Piet Kager in
Current site
Google Scholar
PubMed
Close
,
Johannes Leeuwenburg Medical Research Center, Kenya Medical Research Institute, Nairobi, Kenya

Search for other papers by Johannes Leeuwenburg in
Current site
Google Scholar
PubMed
Close
,
Peter Perkins Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Peter Perkins in
Current site
Google Scholar
PubMed
Close
,
Charles Oster Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Charles Oster in
Current site
Google Scholar
PubMed
Close
, and
Larry D. Hendricks Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Larry D. Hendricks in
Current site
Google Scholar
PubMed
Close
Restricted access

Six Leishmania isolates from 3 indigenous Kenyans (2 isolates from one patient) and 2 Canadian visitors in Kenya were characterized by cellulose acetate electrophoresis. The isolates were compared among themselves and with reference strains of Leishmania donovani, L. aethiopica, L. major, L. tropica, and L. arabica using 9 enzymes: malate dehydrogenase (MDH), malic enzyme (ME), phosphogluconate dehydrogenase (6PGD), glucose-6-phosphate dehydrogenase (G6PD), aspartate aminotransferase (ASAT), adenylate kinase (AK), mannose phosphate isomerase (MPI), glucose phosphate isomerase (GPI), and phosphoglucomutase (PGM). Enzyme migration patterns of isolates from the 3 indigenous Kenyans were indistinguishable from those of 2 L. tropica reference strains. The isolates from the 2 Canadians yielded migration patterns of 7 enzymes that were indistinguishable from those of 2 L. tropica reference strains. However, migration patterns of 2 enzymes, PGM and ME, differed from all migration patterns of the 10 reference strains. Balb/c mice were inoculated with stationary phase promastigotes cultured from 3 stabilates from the lesions of 2 of the Kenyan patients. The mice developed no gross pathological lesions in 6 months time.

All of the study patients developed cutaneous leishmaniasis while living in or visiting districts in Central and Rift Valley Provinces, Kenya. This is the first report of human cutaneous leishmaniasis caused by L. tropica indigenous to Africa south of the Sahara.

Author Notes

Save